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Synaptic control of DNA methylation involves activity-
dependent degradation of DNMT3A1 in the nucleus
Gonca Bayraktar 1,11, PingAn Yuanxiang 1, Alessandro D. Confettura1, Guilherme M. Gomes 1,2, Syed A. Raza3, Oliver Stork2,3,
Shoji Tajima4, Isao Suetake 5,6,7, Anna Karpova1,2, Ferah Yildirim8 and Michael R. Kreutz 1,2,9,10
DNA methylation is a crucial epigenetic mark for activity-dependent gene expression in neurons. Very little is known about how
synaptic signals impact promoter methylation in neuronal nuclei. In this study we show that protein levels of the principal de novo
DNA-methyltransferase in neurons, DNMT3A1, are tightly controlled by activation of N-methyl-D-aspartate receptors (NMDAR)
containing the GluN2A subunit. Interestingly, synaptic NMDARs drive degradation of the methyltransferase in a neddylation-
dependent manner. Inhibition of neddylation, the conjugation of the small ubiquitin-like protein NEDD8 to lysine residues,
interrupts degradation of DNMT3A1. This results in deficits in promoter methylation of activity-dependent genes, as well as synaptic
plasticity and memory formation. In turn, the underlying molecular pathway is triggered by the induction of synaptic plasticity and
in response to object location learning. Collectively, the data show that plasticity-relevant signals from GluN2A-containing NMDARs
control activity-dependent DNA-methylation involved in memory formation.
Neuropsychopharmacology (2020) 45:2120–2130; https://doi.org/10.1038/s41386-020-0780-2
INTRODUCTION
It is widely believed that rapid and reversible DNA methylation is
essential for the stability of long-term memory but very little is
known about how synaptic signals can induce changes in DNA
methylation to elicit enduring alterations in plasticity-related gene
expression [1–6]. In addition, aberrant DNA methylation has been
implicated in neuropsychiatric diseases, including schizophrenia,
bipolar, and major depressive disorders [1, 7, 8]. N-methyl-D-
aspartate receptors (NMDAR) signaling to the nucleus is instru-
mental for learning and memory formation and is altered in
schizophrenia as well as other neuropsychiatric disorders [9, 10].
However, a mechanistic link between NMDAR signaling and DNA
methylation is currently missing.
Compelling evidence exists for learning-induced de novo DNA
methylation with several studies showing the importance of active
DNA methylation as well as demethylation particularly in the
hippocampus during memory consolidation [1, 11–13]. One of the
target genes is the brain-derived neurotrophic factor (BDNF),
which undergoes promoter-specific DNA demethylation in the
CA1 region of the hippocampus during memory consolidation
[14]. The underlying signaling machinery in this process is also not
well understood. It is fundamentally unclear how synaptic signals
conveyed to the nucleus impact mechanisms of DNA methylation
and demethylation of the Bdnf promoter. DNMT3A1 is the major
de novo DNA methyltransferase in the brain and plays a
documented role in activity-dependent DNA methylation
[15, 16]. Impaired spatial learning and memory, as well as
attenuated CA1 long-term potentiation (LTP), have been reported
following a forebrain specific DNMT gene knockout in principal
neurons [16, 17].
It is nowadays widely accepted that memory consolidation
as well as synaptic plasticity not only rely on de novo protein
synthesis but also protein degradation [18–20]. Proteasomal
degradation of proteins in neurons has been studied mainly in
the context of ubiquitylation and sumoylation, whereas neddy-
lation, the attachment of the small ubiquitin-like peptide neural
precursor cell-expressed developmentally down-regulated gene
8 (NEDD8) has not been thoroughly investigated. Here we
show that activation of synaptic GluN2A-containing NMDARs
drives the neddylation-dependent proteasomal degradation
of the principal de novo DNA-methyltransferase in the adult
brain DNMT3A1. Collectively, the data point to a mechanism
that allows for the synaptic control of nuclear DNMT3A1
protein levels thereby creating a time window for reduced
de novo DNA methylation at a subset of target genes. This
signaling pathway highlights how synapse-to-nucleus signaling
might directly impact on DNA methylation and memory
consolidation.
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METHODS
Cell culture and drug treatments
Rat cortices and hippocampi were dissected from embryonic day
18 rats (Sprague Dawley). Cells were plated in a density of 30.000
cells per 18 mm coverslip, grown in 1ml of neurobasal medium
(NB, Gibco) supplemented with B27 medium. Primary neurons
were kept in Neurobasal medium (NB/GIBCO/Life Technologies)
supplemented with B27 (GIBCO/Life Technologies), L-glutamine
(GIBCO/Life Technologies) and penicillin/streptomycin (PAA
Laboratories, Pasching, Austria). On day 4 after plating cortical
neurons were treated with 5 μM cytosine D-arabino-furanoside
(Sigma-Aldrich) in order to prevent proliferation of non-
neuronal cells.
Hippocampal neurons were treated for 10 min, 1 h, 3 h or 6 h at
DIV 14–15 with the following drugs: Bicuculline methiodide
(50 μM, Tocris, Bristol, UK), 4-aminopyridine (4AP, 2.5 mM, Sigma-
Aldrich, St. Louis, MO), MG132 (30 μM, AG Scientific), lactacystin
(15 μM, Sigma-Aldrich, St. Louis, MO), carfilzomib (100 nM,
UBPBio), NVP-AAM007 (50 nM, Novartis), APV (20 μM, Calbiochem),
ifenprodil (10 μM, Tocris, Bristol, UK), nifedipine (10 μM, Santa
Cruz), KN93 (5 μM, Tocris, Bristol, UK) and MLN4924 (5 nM, Cayman
Chemicals, Hamburg, Germany). Hippocampal neurons were
treated for 3, 5 or 10 min with 100 μM N-methyl-D-aspartic acid
(NMDA, Sigma-Aldrich, St. Louis, MO). Cortical neurons were
seeded in T-75 flasks (Thermo Scientific, Rockford, USA). They were
fed with the same neuron chow and proliferation of non-neuronal
cells was arrested by the addition of 1 μM cytosine arabinoside
(Sigma-Aldrich, St. Louis, MO) at DIV 5. Cortical neurons were
treated with 1 μM tetrodotoxin (TTX, Alomone Labs, Jerusalem,
Israel) for 12 h, media was washed-out and Bic/4AP were applied
for 6 h at 21 DIV. HEK293T cells were cultured in DMEM media
supported by fetal bovine serum. In all graphs depicting
quantitative immunocytochemistry, the numbers for each experi-
mental group indicate the number of analyzed neurons derived
from at least two or three independent culture preparations,
where from each culture preparation at least 2 culture wells are
included in the study.
Experimental animals
Neurons for primary cell cultures and slices for electrophysiology
experiments were prepared from brains of Sprague Dawley
(Janvier, France) or Wistar rats (Animal facilities of the Leibniz
Institute of Neurobiology, Magdeburg, Germany). Male C57BL/6J
(10–13 weeks old) mice were used for behavioral experiments
(Charles River/Animal facilities of the Leibniz Institute of
Neurobiology, Magdeburg, Germany). GluRε1 (GluN2A) knock-
out (KO) mice were obtained from RIKEN Japan (RBRC01813).
Animals were housed in groups of up to 5 in individually
ventilated cages (IVCs, Green line system, Tecniplast) under
controlled environmental conditions (22 °C ± 2 °C, 55% ± 10%
humidity, 12 h light/dark cycle, with lights on at 06:00). Food and
water were available ad libitum. All procedures and animal care
were consented and performed under established standards of
the German federal state of Sachsen-Anhalt, Germany in
agreement with the European Communities Council Directive
(2010/63/EU) and approved by the local authorities of Sachsen-
Anhalt/Germany/Regierungspräsidium Halle Sachsen-Anhalt/
Germany.
Methylation analysis
DNA from CA1 was extracted using Chargeswitch DNA extrac-
tion kit from Invitrogen (Carlsbad, CA, USA) according to the
instructor’s manual. Methylation-sensitive restriction enzyme-
dependent methylation analysis was performed using OneStep
q-Methyl Kit (Zymo, Irvine, CA, USA) following the instructions
given in the manual using 20 ng DNA for each sample.
For methylated DNA immunoprecipitation (MeDIP) experiments,
the extracted DNA was then subjected to fragmentation via a
sonicator (Picoruptor, Diagenode, Seraing, Belgium) with 30 s on
and 90 s off cycles using 1.5 ml Bioruptor microtubes. The
efficiency of the sonication was established by running the
fragmented DNA samples on agarose gels, which confirmed the
accumulation of fragmented DNA to be mainly within a range of
200–600 bp. Afterward MeDIP experiments were carried out
using the MagMeDIP kit (Diagenode, Seraing, Belgium) following
the user guide with ~750 ng fragmented DNA as starting
material. The methylation levels were assessed by qPCR and
evaluated using the formula given in the user guide for
both kits. The forward primer used in the OneStepqMethyl-Kit
was 5′-TATGACAGCTCACGTCAAGG-3′ and reverse primer was
5′-CCTTCAGTGAGAAGCTCCAT-3′, containing three methylation-
sensitive restriction enzyme sites. The forward primer used in
the MeDIP-qPCR study for BDNF promoter IV was 5′-GCATGC
AATGCCCTGGAACGG-3′ and the reverse primer was 5′-GAG
GGCTCCACGCTGCCTTG-3′, and forward primer for BDNF pro-
moter I 5′-TACCTGGCGACAGGGAAATC-3′ and reverse primer 5′-
GCGCCCTAGCACAAAAAGTT-3′.
Percent methylation at single CpG sites in Bdnf IV promoter was
determined using the bisulfite sequencing method. For this
genomic DNA (gDNA) was extracted from 21 DIV cultured cortical
neurons treated with Bic/4AP for 6 h or neurons that did not
receive any treatment. The extraction was performed using
Chargeswitch DNA extraction kit, as described above. 200 ng of
gDNA was used for bisulfite conversion (EZ DNA methylation-
gold, Zymo Research). To amplify the region of interest 1 to 2 μl of
bisulfite-converted DNA was run in a PCR using specific primers
spanning 19 CGs. Bisulfite sequencing primer sequences used to
assess CpG methylation levels of the rat Bdnf promoter IV were:
Forward 1–5′-TTTATAAAGTATGTAATGTTTTGGAA-3′, Forward 2–5′-
AGTTAGTATGAAATTTTTTAGTTTTTGTT-3′, Reverse 1–5′-TTCAATA
AAAAACTCCATTTAATCTA-3′, Reverse 2–5′-TATCAAAATAAACATCA
AAACAACTAC-3′. The sequencing was performed on the MiSeq
with a 600 cycle v3 kit, generating 300 base pair end reads.
Mapping of the reads and methylation level extractions were
performed using Bismark [21]. Average methylation rate of each
CpG site was quantified using the methylKit R package [22]. The
groups were compared using a Chi-square test and the correction
applied was the false discovery rate (FDR) [23].
Quantitative real time-PCR
14 DIV hippocampal neurons were treated with 50 μM bicucul-
line methiodide and 2.5 mM 4AP with or without 5 nM MLN4924
for 6 h. DMSO was used as a sham control. Following the
treatment, neurons were immediately harvested in lysis buffer
and total RNA was isolated (RNeasy plus mini kit, Qiagen,
Valencia, CA, USA). 50 nanograms of RNA were reverse
transcribed using random nonamers (Sigma-Aldrich, St. Louis,
MO, USA) according to the manufacturer’s instructions (Sensi-
script, Qiagen). BDNF exon IV and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) mRNA (as a reference gene) were
amplified using the iScript RT-PCR iQ SYBR Green Supermix
(BIORAD, Hercules, CA, USA) in a real-time quantitative PCR
(qPCR) detection system (LC480, Roche, Basel, Switzerland) using
the following primers: Bdnf exon IV forward 5′-GCAGCTGCCTT
GATGTTTAC-3′ and reverse 5′-CCGTGGACGTTTGCTTCTTTC-3′;
Dnmt3a1 forward 5′- CCCTCAGATCTGCTACCCAA-3′ and reverse
5′-TGCTCTGGAGGCTTCTGGTG-3′; Dnmt3a2 forward 5′-CTCACAC
CTGAGCTGTACTGCAGAG-3′ and reverse 5′-CTCCACCTTCTGGG
ACTCCCCAGAG-3′; Gapdh forward 5′-TGCTGAGTATGTCGTGGAG-
3′ and 5′-ACCCAGAAGACTGTGGATGG-3′; Gapdh reverse 5′-
GTCTTCTGAGTGGCAGTGAT-3′ and 5′-CACATTGGGGGTAGGAAC
AC-3′. Each sample reaction was run in duplicate and Ct values of
the reference genes from the samples were subjected to Grubbs’
outlier test (http://www.graphpad.com/quickcalcs/Grubbs1.cfm).
The relative expression levels were analyzed using the 2−ΔΔCt
method with normalization relative to GAPDH.
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Immunocytochemistry
Following drug treatment, cells were fixed either in methanol or in
4% paraformaldehyde (PFA) and immunostaining was performed
with primary antibodies specific for the DNMT3AN-terminus,
CUL4B (Proteintech, catalog #12916-1-AP), GFAP (Synaptic Sys-
tems, catalog #173011), HOMER1 (Synaptic Systems, catalog
#160011), NEDD8 (Proteintech, catalog #16777-1-AP), MAP2
(Sigma-Aldrich, catalog #M4403), 5meCytosine (Calbiochem,
catalog #MABE146, clone 33D3), Synaptophysin1 (Synaptic Sys-
tems, catalog #101004); secondary antibodies anti-rabbit/mouse-
Alexa Fluor 488/568 linked (Molecular Probes Europe BV, Leiden,
The Netherlands), anti-rabbit/mouse-CyTM5-conjugated (Dianova,
Hamburg, Germany) and DAPI (Sigma-Aldrich, catalog #D9564).
Live immunostaining was performed for the detection of the
surface expression of the GluN2A subunit of NMDARs. To this end,
the GluN2A antibody (Alomone Labs, #AGC-002) was applied in
cell media for 20 min, then cells were fixed and staining was
performed as outlined above.
Confocal laser scanning microscopy and image analysis
The SP5 CLSM system (Leica-Microsystems, Mannheim, Germany)
equipped with Diode (405 nm) and Argon (488, 561, and 633 nm)
laser lines was used for quantitative immunocytochemistry. Z-
stack images of neurons were taken using the ×63 oil-immersion
objective (Leica, Mannheim, Germany). Confocal images of triple-
stained neurons were taken with Plan Apo ×63 oil NA 1.4 objective
lenses. All images were acquired sequentially to avoid crosstalk
between channels. The acquisition parameters were kept the
same for all scans. Regions of interest (ROI) were drawn around
nuclei, as delineated by DAPI staining. These ROI were then
applied to a corresponding image of antibody staining from which
the mean average intensity was collected to determine nuclear
immunoreactivity levels using Image J software (NIH, Rasband, W.
S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland,
USA, http://imagej.nih.gov/ij/, 1997–2014).
The total number of dendritic spines per 20 μm secondary
dendrites of the primary hippocampal neurons, which received
5 nM or 1 μM MLN4924 treatment at basal conditions or with
synaptic stimulation using Bic/4AP were counted based on the
Homer1 staining. The total synapse number per 20 μm secondary
dendrites of the primary hippocampal neurons following Cul4B
knockdown were counted based on the colocalization of Homer1
and Synaptophysin1. Surface expression of GluN2A was evaluated
in primary hippocampal neurons following the knockdown
of Cul4B.
Fluorescent microscopy and image analysis
The number of dendrites crossing each circle was counted manually.
Studies of GluN2A knockdown on hippocampal primary hippocam-
pal neurons were also carried out using Zeiss Axio Imager A2
fluorescent microscope (Zeiss, Jena, Germany) with Cool Snap EZ
camera (Visitron System) and MetaMorph Imaging software (MDS
Analytical Technologies). Up to 3 coverslips were treated individually
and processed per group. The same exposure time and intensity
were taken for each coverslip among the different groups. Upon
background subtraction using Fiji software, images of fluorescent
positive puncta were measured along secondary dendrites, right
after the branching point. The synaptic immunofluorescence
intensities were assessed in a region of 400 nm× 400 nm square
set by the mask in the channel for Homer1, a synaptic marker.
The mask was created semi-automatically using Openview software.
The intensities of the puncta positive for GluN2A were measured at
points of co-localization with Homer1; values were normalized to
mean of the control and plotted.
Intrahippocampal injections
Mice were anesthetized with 5% isofluorane in O2/N2O mixture.
Mice were placed in a stereotaxic frame (World Precision
Instruments) and anesthesia was maintained with 1.5% isofluor-
ane using gas anesthesia system (Rothacher Medical GmbH.,
Switzerland). After craniotomy, 10 μl NanoFil microsyringes (World
Precision Instruments) containing 33G injection needles were
lowered into the dorsal CA1 area under stereotactic guidance with
the coordinates anterioposterior (AP) −2.0 mm, mediolateral (ML)
± 1.5 mm from Bregma and dorsoventral (DV) −0.14 mm from
brain surface. Each animal received 1.5 μl/hemisphere bilateral
infusion of drug (MLN4924) while (saline with respective volume
of DMSO) as sham control, at an infusion rate of 0.5 μl/min.
Overexpression and knockdown experiments
The overexpression experiments in HEK-293T cells were per-
formed using the following constructs: C2-eGFP-hDNMT3A
(Clontech, subcloned from pcDNA3/Myc-DNMT3A1, which was a
gift from Arthur Riggs, Addgene plasmid #35521), C2-eGFP-
hDNMT3A2 (Clontech, subcloned from pcDNA3/Myc-DNMT3A2,
which was a gift from Arthur Riggs, Addgene plasmid #36941), pK-
MYC-C3 (gift from V. Horejsi Lab, Prague, Czech Republic),
pcDNA3-myc3-CUL4B (gift from Yue Xiong, Addgene plasmid
#19922), pcDNA3-myc3-NEDD8 (gift from Yue Xiong, Addgene
plasmid #19943), pcDNA3-HA-NEDD8 (gift from Edward Yeh,
Addgene plasmid #18711), CUL1, CUL2, CUL3, CUL4A, CUL4B,
CUL5 and CUL7 in pcDNA3-myc3 backbone (which were a gift
from Yue Xiong, Addgene plasmid #19896, #19892, #19893,
#19951, #19922, #19895, #20695 respectively). The vector for the
expression of constitutively active CaMKIV with a nuclear
localization signal (eGFP-CaMKIV-3xNLS) and dominant negative
CaMKIV are were kindly provided by Dr. Gina Turrigiano (Waltham,
USA) [24, 25]. The shRNA constructs to knock down human
DNMT3A1/3A2 and scrambled controls were hDNMT3A shRNA,
pSMP-DNMT3A1 and pSMP-Luc (a gift from George Daley,
Addgene plasmid #36380, Addgene plasmid #36394, respectively).
shRNA targeting, ratDNMT3A and scrambled control were cloned
into pZ-off vector with the following sequences: 5′-CCCAAGGT
CAAGGAGATCA-3′ and 5′-GCTTCGCGCCGTAGTCTTA-3′, respec-
tively. shRNA targeting rat-Nedd8, human-Nedd8 and scrambled
control were cloned into pSuper vector with the following
sequences: 5′-GCGGCTCATCTACAGTGGCAA-3′, 5′-GAGGCTCATC
TACAGTGGCAA-3′, 5′-CTTCGCGCCGTAGTCTTA-3′, respectively.
The target shRNA sequence that efficiently knocked down rat-
CaMKIV was 5′-CTAAGAAGCGGCTGACTAC-3′.
Acute hippocampal slice preparation and electrophysiology
Hippocampi from 8 weeks old male Wistar rats (House strain, LIN,
Magdeburg) were cut using a vibratome (LeicaVT1000S, Nussloch,
Germany) into 350 μm thick slices. The hippocampal slices were
incubated for 2 h in carbogenated (95% O2–5%CO2) artificial
cerebrospinal fluid (ACSF, containing in mM: 110 NaCl, 2.5 KCl, 2.5
CaCl2·2H2O, 1.5 MgSO4·7H2O, 1.24 KH2PO4, 10 glucose, 27.4
NaHCO3, having a pH of 7.3) at room temperature. Then slices
were transferred into a recording chamber (at 31 ± 1 °C). Field
excitatory postsynaptic potentials (fEPSPs) were evoked by
stimulation of CA1 Schaffer-collateral fibers with metal electrodes.
fESPSs were recorded with ACSF filled glass capillary microelec-
trodes (3–5 MΩ) and amplified by an extracellular amplifier (EXT-
02B, npi, Germany) and digitized at a sample frequency of 5 kHz
by Digidata 1401 plus AD/DA converter (CED, England). Stimula-
tion strength was adjusted to 30% – 40% of the maximum fEPSP-
slope values. Single stimuli were applied every 30 s (at 0.0333 Hz)
and were averaged every 3 min. After a 30 min stable baseline
recording, MLN4924 was applied into the bath. 30 min later, late-
long term potentiation (L-LTP) was induced by tetanization
consisting of three 1 s stimulus trains at 100 Hz with a 6min
inter-train interval where the width of the single stimulus was
0.1 ms. MLN4924 was dissolved in DMSO and diluted in ACSF at
final concentration (5 μM, or 50 nM) applied 30min before the first
tetanus. Data are represented as mean ± SEM.
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Tissue collection and analysis
After the LTP recordings, only the potentiated CA1 region of the
Hippocampus was collected from the acute slices. The tissue was
either subjected to RNA or DNA extraction for transcription or
promoter methylation analysis, respectively, or for total protein
extraction for western blotting. For the experiments investigating
learning-dependent DNMT3A1 degradation, mice were sacrificed
3 or 6 h after training and the CA1 region of the hippocampus was
dissected. Bilateral intrahippocampal MLN4924 (7.5 pmol/site) or
saline infusions were performed immediately after training.
Immunoprecipitation experiments
Endogenous IP experiments were performed from cultured rat
cortical neurons. 50 μl dynabeads Protein G (ThermoFischer
Scientific, Waltham, MA, USA) were blocked using albumin from
chicken egg white (Sigma-Aldrich, St. Louis, MO, USA), while
rocking for 30min. Then, the dynabeads protein G were incubated
with 2–3 μg of rabbit polyclonal anti-CUL4B antibody (Proteintech,
catalog #20882-1-AP), while gently rotating for 2 h at 4 °C. Nuclear
protein extracts were then incubated with antibody-bound-
protein G dynabeads overnight at 4 °C. The next day, following
several washes with ice-cold TBS-T, the samples were eluted using
4× Laemmli sample buffer.
Heterologous co-immunoprecipitation (het-coIP) experiments
were performed in HEK-293T cells. Transfection of HEK-293T
cells was performed with constructs pcDNA3-myc3-CUL4B, C2-
eGFP-hDNMT3A, and pK-MYC-C3. 3 h prior to harvesting the
cells, either the proteasome inhibitor MG132 (30 μM) or DMSO
as sham control was applied to the cells. 24 h after transfection
cells were harvested. In the het-coIP experiment in which the
effect of neddylation was studied, transfections were performed
using the constructs pcDNA3-myc3-CUL4B, C2-eGFP-hDNMT3A,
pK-MYC-C3, and myc3-NEDD8. 24 h after transfection HEK-T cells
were treated with NEDD8-activating enzyme inhibitor MLN4924
(94 nM) or DMSO as sham control for 24 h. MG132 application
was done as mentioned above. Cell lysate extracts were
incubated with the anti-GFP microbeads (MiltenyiBiotec GmbH,
Gladbach, Germany) for 1 h. Eluted samples were run on SDS-
PAGE.
Western blot analysis
Total homogenates were prepared from mouse and rat brain or
cultured cortical neurons by performing the lysis in 10 mM Tris/
HCl pH 7.5, 0.5% TritonX, and a protease inhibitor cocktail
(Roche, catalog #04693116001) containing TBS. 4× Laemmli
buffer was added to produce a final dilution of 1.5×. Following
10 min-incubation at 95 °C, samples were ready for protein
analysis. HEK-293T cells were harvested in TBS, which contained
the protease inhibitor cocktail. Cells were lysed in 1% Triton-X
containing lysis buffer; centrifuged for 30 min at 21,000 rpm
and the supernatant fraction was collected. Protein estimation
was performed either by amidoblack or BCA assay (Thermo
Scientific). Western blots were then performed using 4–20%
gradient polyacrylamide gels. The following antibodies were
used in this study: DNMT3AN (1:2000) and DNMT3A-mid
(1:2000), CUL4B (1:1000, Proteintech, catalog #12916-1-AP),
NEDD8 (1:1000, Proteintech, catalog #16777-1-AP), FK1 (1:1000,
Enzo, catalog #BML-PW8805), β-Actin (1:2000, Sigma-Aldrich,
catalog #A5441), myc-tag (1:1000, Cell Signaling, catalog #2276),
and horseradish peroxidase-coupled goat anti mouse/rabbit
IgG-HRP linked secondary antibodies (1:20000, Jackson Immu-
noresearch Laboratories, catalog #115035003 and #111035003,
respectively). Quantification of immunoblots was done with
ImageJ software (NIH, Maryland, USA). Integrated density values
were evaluated for the analysis. When necessary, data from
individual experiments performed at different time points were
normalized to respective controls and pooled together with
other data sets.
Object location memory
Object location memory was performed in a square arena (50 × 50 ×
50 cm) under mild light conditions. Briefly, the task consisted of a
habituation session, training and test. During habituation, animals
were allowed to explore the empty arena for 20min. Twenty-four
hours later, a training session took place, where animals were free to
explore a pair of similar objects (made of plastic mounting bricks),
placed in the arena, for 20min. A test session was performed 6 h
after training, where one of the objects was placed in a new
position, and again, animals were free to explore the two objects for
20min. All three sessions were video-recorded and behavior was
analyzed offline using ANY-maze software (ANY-mazeTM Video
Tracking System, version 4.50, Stoelting Co. Wood Dale, USA).
Exploration was recorded only when the animal touched or reached
the object with the nose at a distance of less than 2 cm. The time
mice spent exploring the objects was recorded, and the discrimina-
tion index was then calculated, taking into account the difference of
time spent exploring the new and familiar position ([(Tnovel –
Tfamiliar)/(Tnovel+ Tfamiliar)] × 100). An experimenter blind to
treatment conducted the experiment and analyzed the data.
Chambers and objects were thoroughly cleaned with 10% ethanol
before and after each animal was tested.
Statistical analysis
The data were analyzed by one-way ANOVA and unpaired one/two-
tailed Student’s t-test. Two-way ANOVA followed by Bonferroni’s
post-hoc test was employed to compare means from multiple
groups. Quantitative real-time PCR data were subjected to Grubbs’
outlier test and analyzed by either unpaired two-tailed Student’s
t-test or two-way ANOVA, which was followed by Bonferroni’s post
hoc test, where applicable. The Mann Whitney U-test was used to
compare the Averaged field potentials (300 – 360min) between two
groups of differentially treated slices. Error bars present S.E.M. except
when otherwise stated. Statistical analyses were performed in
GraphPad (GraphPad Software, Inc., La Jolla, USA).
RESULTS
Synaptic activity controls levels of DNMT3A1 in neuronal nuclei
DNMT3A1 is the major de novo DNA methyltransferase expressed
in the adult brain [15]. In addressing the cellular localization of this
enzyme using an antibody that recognizes an N-terminal region
[26] specific for DNMT3A1 (Fig. S1A–D), we found a prominent
nuclear localization in hippocampal primary neurons and much
fainter staining hardly above background in astrocytes (Fig. 1a),
indicating that DNMT3A1 is mainly expressed in neurons. This
finding prompted us to ask next whether synaptic activity might
regulate nuclear DNMT3A1 protein levels. When we induced burst
firing of excitatory synapses in hippocampal primary neurons with
the GABA-A receptor antagonist bicuculline (Bic) and the
potassium channel blocker 4-amino-pyridine (4AP), we observed
a prominent reduction in the nuclear immunofluorescence of
DNMT3A1 (Fig. 1b, c), a finding that was confirmed by quantitative
immunoblot analysis of cell lysates from cortical primary neurons
(Fig. 1d–f). Enhancing excitatory activity for 10min with Bic/4AP
was sufficient to reduce DNMT3A1 immunofluorescence for 3 h
following stimulation (Fig. 1g, h), while excitotoxicity, elicited with
bath application of 100 µM NMDA for 10 min, a protocol that
results in extrasynaptic NMDAR activation and delayed cell death,
had no effect [27]. Of note, the reduction of DNMT3A1 protein
levels lasted at least for 24 h and returned back to baseline
expression only after 72 h (Fig. S1E–J).
Synaptic GluN2A-containing NMDARs drive the degradation of
nuclear DNMT3A1
The activity-dependent degradation of DNMT3A1 was blocked in
the presence of the competitive NMDAR antagonist 2-amino-5-
phosphonopentanoic acid (APV) (Fig. 2a, b). Interestingly, the
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application of the antagonist NVP-AAM077, which mainly targets
di-heteromeric GluN2A-containing NMDARs [28] in low doses,
completely prevented degradation as evidenced by quantitative
immunocytochemistry (Fig. 2c, d) and immunoblotting (Fig. 2e, f).
In addition, shRNA-induced protein knockdown (Fig. S2A, B) of
GluN2A confirmed a requirement for NMDARs specifically contain-
ing this subunit to elicit degradation of DNMT3A1 (Fig. 2h, i),
whereas application of the GluN2B antagonist ifenprodil had no
effect (Fig. 2j, k). Co-application of the L-type Ca2+-channel
blocker nifedipine (Fig. S2C, D) or the CaMKII and CaMKIV inhibitor
KN93 to the stimulation buffer also hindered nuclear DNMT3A1
degradation (Fig. S2E, F). Likewise, CaMKIV shRNA knockdown
clearly reduced DNMT3A1 degradation in response to enhanced
synaptic activity (Fig. S2G–I). Similarly, nuclear overexpression of a
dominant negative form of CaMKIV reduced activity-dependent
degradation, whereas constitutively active CaMKIV [19, 20] had the
opposite effect (Fig. S2J–L). Taken together, these experiments
indicate that brief activation of synaptic GluN2A-containing
NMDARs is a potent stimulus to control DNMT3A1 protein levels
in the nucleus and that synaptic control probably involves the
induction of backpropagating dendritic action potentials and
nuclear calcium waves which in turn activate CaMKIV, upstream of
DNTM3A1 downregulation.
Proteasomal degradation of DNMT3A1 requires neddylation
We next examined which mechanisms might contribute to
DNMT3A1 downregulation and found that the proteasome
inhibitors MG132, lactacystin or carfilzomib, which all operate
via different mechanisms [29–31], completely abolished the effect
of GluN2A stimulation (Fig. S3A–F). Since we found no con-
comitant alteration of Dnmt3a1 mRNA levels (Fig. S3G-I), these
data suggest that proteasomal degradation controls the protein
levels of the enzyme in an activity-dependent manner.
Potential mediators of DNMT3A1 degradation are members of
the family of Cullin proteins [32]. Cullin family members combine
with RING proteins to form Cullin-RING E3 ubiquitin ligases [33]
and neddylation is a prerequisite for their activation in the
nucleus. Neddylation has been studied only recently in neurons
[34, 35] and the subcellular distribution of NEDD8 in neurons
has not been determined yet. We found that NEDD8 is
abundantly localized in the nucleus of hippocampal primary
neurons, whereas immunofluorescence intensity was much
weaker at synapses (Fig. 3a). We observed heterologous co-
immunoprecipitation of DNMT3A1 with CUL4B, CUL1, CUL3,
CUL4, CUL7, but not with CUL2 and CUL5 from HEK293T cell
lysates (Fig. S4A). In addition, we found that poly-ubiquitination
of DNMT3A1 was elevated following forced expression of CUL4B
in HEK293T cells (Fig. S4B, D), which was chosen as an example
because of its abundance in the brain. Conversely, shRNA-based
CUL4B protein knockdown resulted in reduced DNMT3A1 poly-
ubiquitination (Fig. S4E). The neddylation inhibitor MLN4924 se-
lectively inhibits the NEDD8-Activating-Enzyme (NAE) at very low
concentrations [36]. Accordingly, poly-ubiquitination of immuno-
precipitated DNMT3A1 was reduced in cells that were subjected
to MLN4924 treatment (Fig. S4F). Moreover, neddylated CUL4B
was co-immunoprecipitated with DNMT3A1 (Fig. S4G).
Following this, we asked whether neddylation of Cullins might
be involved in controlling activity-dependent DNMT3A1 protea-
somal degradation in neurons. With co-immunoprecipitation
experiments on endogenous proteins extracted from cortical
primary neurons using a CUL4B specific antibody as pars pro toto
we revealed that neuronal CUL4B and DNMT3A1 might be in one
complex in vivo (Fig. 3b). Acute treatment of hippocampal primary
neurons with concentrations of MLN4924 as low as 5 nM
prevented DNMT3A1 degradation (Fig. 3c, d). Of note, acute
treatment of primary neurons for 6 h with either a low (5 nM) or
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Fig. 1 Synaptic activity regulates DNMT3A1 protein levels in neurons. a Nuclear DNMT3A1 immunofluorescence is prominent in MAP2-
positive neurons but much less in GFAP-positive astrocytes at 15 DIV hippocampal cultures. Scale bars are 20 μm. b, c Downregulation of
DNMT3A1 protein levels in 14–15 DIV hippocampal primary neurons following treatment with Bic/4AP for 1 h, 3 h or 6 h as evidenced by
quantitative immunocytochemistry. Scale bar is 20 μm. Unpaired Student’s t-test **p < 0.01, ***p < 0.001. d–f DNMT3a1 protein levels are
decreased following the removal of tonic inhibition in DIV 21 cortical neurons. β-Actin was used as an internal control for normalization.
Student’s t-test *p < 0.05. g, h Hippocampal neurons were treated with Bic/4AP for 10min or 3 h. Media from 10min-long treated neurons was
washed out and cells were kept for 3 h before fixation. Both treatments were equally effective to reduce nuclear DNMT3A1
immunofluorescence. Application of 100 μM NMDA for 10min had no effect. Unpaired Student’s t-test **p < 0.01, ***p < 0.001. Error bars
present S.E.M. Sample numbers for each experimental group indicate neurons from three different culture preparations.
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even a high dose of MLN4924 (1 µM) did not alter the total
number of spines (Fig. S5A, B) as it was reported previously with a
higher concentration and long-term treatment [34, 35]. Moreover,
we observed that nuclear NEDD8 staining intensity was not
altered following Bic/4AP treatment (Fig. 3e, f), which excludes the
possibility that activity-dependent nucleocytoplasmic shuttling of
NEDD8 contributes to DNMT3A1 degradation. In addition, 5meC
immunocytochemistry revealed that no gross quantitative altera-
tions in global DNA methylation occur following sustained
stimulation of synaptic GluN2A-containing NMDARs (Fig. 3e, g).
However, enhanced synaptic activity resulted in rapidly increased
neddylation of CUL4B (Fig. 3h, i), whereas shRNA knockdown of
NEDD8 (Fig. S5C–E) prevented activity-dependent degradation of
DNMT3A1 (Fig. 3j, k). Collectively, the biochemical, pharmacolo-
gical and shRNA knockdown experiments show that synaptic
activation of GluN2A-containing NMDARs will drive neddylation of
Cullin-ligases in the nucleus, which is a prerequisite for DNMT3A1
degradation.
Synaptic plasticity inducing stimuli elicit DNMT3A1 degradation in
a GluN2A-dependent manner
We then addressed whether induction of NMDAR-dependent LTP,
a form of plasticity that is considered to be a cellular model of
learning and memory, impacts nuclear DNMT3A1 protein levels.
When we induced LTP in the hippocampus with high-frequency
stimulation of Schaffer-collaterals (Fig. 4a), we found a significant
downregulation of DNMT3A1 protein levels within 6 h in the
potentiated CA1 region following tetanization of the slices (Fig. 4b,
c). Moreover, the expression of late-LTP is neddylation-sensitive
and field excitatory postsynaptic potentiation slope values
returned to baseline within three hours when the slices were
treated with the NEDD8 inhibitor MLN4924 like reported
previously [37] (Fig. 4d–f).
We subsequently investigated whether following the induction
of LTP signaling of GluN2A-containing NMDARs to the nucleus is
crucial in neddylation-dependent degradation of DNMT3A1.
Interestingly, DNMT3A1 protein levels were already clearly higher
in hippocampal tissue homogenates of GluN2A knockout mice as
compared to wild-type controls (Fig. 4g, h). GluN2A knockout mice
show reportedly impaired hippocampal LTP [38] but a stronger
tetanic stimulation rescues this impairment and the saturation
level of LTP remains unaltered [39]. We could replicate these
published findings (Fig. S6A, C) and found that despite the
induction of LTP with a stronger protocol no reduction in nuclear
DNMT3A1 protein levels like in wild-type mice was detectable
(Fig. 4i–l). Notably, while we observed a negative correlation
between the strength of LTP and the magnitude of DNMT3A1
degradation in wild-type control animals (Fig. S7D) no correlation
was seen in GluN2A -/- mice despite recovered LTP. Thus, GluN2A
signaling in synaptic plasticity and not the induction of LTP as
such is instrumental in controlling nuclear protein levels of
DNMT3A1.
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Fig. 2 GluN2A-dependent NMDAR signaling regulates nuclear DNMT3A1 protein levels in 14–15 DIV hippocampal primary neurons. a, b
Treatment with the NMDAR antagonist APV (20 μM) prevented the reduction in the nuclear levels of DNMT3A1 following synaptic stimulation
by Bic/4AP for 6 h. c, d Treatment with the GluN2A inhibitor NVP-AAM077 (50 nM) prevented the reduction in the nuclear levels of DNMT3A1
following synaptic stimulation by Bic/4AP for 6 h. Two-way ANOVA followed by Bonferroni’s post hoc test. e Timeline view of hippocampal
neuron treatment by Bic/4AP for 6 h with or without NVP-AAM077. f, g Quantitative immunoblotting revealed the inhibition of DNMT3A1
degradation by the use of NVP-AAM077. One-sample t-test is performed while the hypothetical value is set to 100. h, i shRNA-based
knockdown of GluN2A in the presence of synaptic stimulation by Bic/4AP for 6 h prevented the DNMT3A1 degradation. j, k Treatment with
the GluN2B subunit inhibitor ifenprodil (10 μM) in the presence of synaptic stimulation with Bic/4AP for 6 h did not prevent the reduction in
the nuclear levels of Dnmt3A1. Scale bars, 20 μm. Two-way ANOVA followed by Bonferroni’s post hoc test. ***p < 0.001, n.s. not significant.
Error bars present S.E.M. Sample numbers for each experimental group indicate neurons from three different culture preparations.
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Neddylation facilitates Bdnf gene expression
In the adult brain, BDNF has principal functions in synaptic
plasticity, learning, and memory [40]. Bdnf gene expression is
controlled by eight promoters [41] and among those, particularly
promoter IV activity is strongly stimulated by the calcium influx
through synaptic NMDARs [14, 42]. DNA methylation of the Bdnf IV
promoter has been studied previously also in the context of
neuropsychiatric disorders [43, 44]. We could replicate these
findings and profiled the changes in DNA methylation levels
following neuronal activity by the 6 h-long Bic/4AP treatment with
bisulfite sequencing that cover the 19 CGs in Bdnf IV gene
promoter (Fig. S7A). We, therefore, chose Bdnf IV gene expression
to test whether neddylation and activity-dependent degradation
of DNMT3A1 might impact DNA methylation of promoters of
plasticity-related genes and corresponding gene expression.
Quantitative real-time PCR experiments first revealed that Bdnf
IV mRNA expression is increased by enhanced synaptic activity in
primary hippocampal neurons and this increase in transcript levels
was significantly lower in the presence of MLN4924 (Fig. S7B).
Comparable results were obtained in acute hippocampal slices
following high-frequency stimulation of Schaffer-collaterals
(Fig. S7C) and importantly, the LTP-induced increase in Bdnf IV
transcript levels was reduced in the presence of the NEDD8-
inhibitor (Fig. S7C).
We next addressed whether increased Bdnf IV mRNA produc-
tion was correlated with the demethylation of the Bdnf IV
promoter in acute slices following LTP induction, as predicted by
the degradation of DNMT3A1. First, methylation specific restric-
tion enzyme analysis was performed using primers that span the
Bdnf IV promoter sequence possessing three different restriction
sites (Fig. S7G). Tetanized CA1 samples revealed a reduction in
Bdnf IV promoter methylation, whereas increased promoter
methylation was observed for the group that received high-
frequency stimulation while being treated with MLN4924
(Fig. S7D). A subsequent series of MeDIP-qPCR experiments
were performed using tetanized CA1 tissue samples following
Fig. 3 DNMT3A1 degradation is a neddylation-dependent process. a NEDD8 is abundantly expressed in the nucleus of 16 DIV hippocampal
neurons whereas weaker staining was observed at synapses. Scale bar 20 μm (top panel), 5 μm (lower panel). b Immunoprecipitation of CUL4B
protein from nuclear extracts of cortical primary neurons (top panel) results in co-precipitation of DNMT3A1 (lower panel, indicated with an
arrow). c, d Hippocampal primary neurons were treated with Bic/4AP for 6 h in the presence or absence of MLN4924 (5 nM). Scale bars, 20 μm.
Quantitative immunocytochemistry revealed that blocking neddylation prevents DNMT3A1 degradation. e Representative immunofluores-
cence images of nuclear NEDD8 and total cytosine methylation (5meC) at basal conditions or after treatment with Bic/4AP for 6 h. Scale bar is
20 μm. f, g Upon synaptic activation nuclear NEDD8 and 5meC levels remained unchanged. Unpaired Student’s t-test. n.s. not significant. h, i
CUL4B was immunoprecipitated from nuclear extracts of primary cortical neurons and neddylated CUL4B was quantified. Following 10min of
synaptic stimulation, the amount of neddylated CUL4B was increased. Unpaired Student’s t-test **p < 0.01. j, k shRNA knockdown of NEDD8 in
hippocampal primary neurons reduced DNMT3A1 degradation following 10min-long Bic/4AP treatment and fixation of cells 3 h after
washout of the drug-containing-media. Two-way ANOVA followed by Bonferroni’s post-hoc test. ***p < 0.001, scale bar, 20 μm. Error bars
present S.E.M. Sample numbers for each experimental group indicate neurons from three different culture preparations.
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the induction of LTP and confirmed the change in promoter
methylation. Less amplicons were generated with primers
targeting the Bdnf IV promoter that cover multiple cytosine
residues (Fig. S7H) known to regulate mRNA expression (Fig. S7E).
More amplicons were detected in MLN4924-treated slices
following the induction of LTP (Fig. S7E), indicating increased
promoter methylation. Among the different Bdnf promoters that
were investigated, activity-dependent DNA methylation is
particularly prominent for promoter IV, whereas promoter I
methylation was not altered following either LTP induction or
NEDD8 inhibition with MLN4924 (Fig. S7F).
DNMT3A1 is degraded in the hippocampus as a result of learning
In the final set of experiments, we investigated whether DNMT3A1
degradation occurs in vivo as a result of CA1-dependent learning
and whether this degradation and memory formation is
neddylation-sensitive. Formation of a memory for the spatial
location of objects in an open field (Fig. 5a) requires synaptic
activity of CA1 neurons [45, 46] and is responsive to changes in
the expression of BDNF [47, 48]. We observed that DNMT3A1
protein levels were reduced in mice for three hours following
training (Fig. 5b, c). DNMT3A1 protein levels returned to control
values within 6 h, which may reflect less intense synaptic activity
as compared to tetanization of slices by high-frequency stimula-
tion (Fig. 5d, e). Bilateral intrahippocampal infusion of MLN4924
into CA1 immediately after object location learning (Fig. 5f)
resulted in a disturbance of object location memory, as indicated
by profoundly reduced discrimination of novel and familiar object
locations when compared to mice that received vehicle infusion
(Fig. 5g). Interestingly, the learning impairment in MLN4924
treated mice was associated with the prevention of DNMT3A1
degradation (Fig. 5h, i). Protein levels were significantly higher in
mice injected with MLN4924 three hours after training compared
to vehicle-injected mice (Fig. 5h, i). Six hours following training
DNMT3A1 protein levels were no longer different between
treatment groups and returned to baseline levels (Fig. 5j, k).
DISCUSSION
Compelling evidence exists for the necessity of active DNA
methylation as well as demethylation during memory consolida-
tion in the hippocampus [1, 2, 11–13]. However, the underlying
signaling machinery is not understood and it is essentially unclear
how synaptic signals conveyed to the nucleus impact DNA
methylation and demethylation. Here, we show that activation of
synaptic GluN2A-containing NMDARs drives the neddylation-
dependent proteasomal degradation of DNMT3A1, the principal
de novo DNA-methyltransferase in the adult brain.
The finding that signals deriving from synaptic GluN2A-
containing NMDARs evoke degradation of DNMT3A1 raises several
Fig. 4 The NEDD8 inhibitor MLN4924 impairs LTP in rat hippocampal slices and degradation of DNMT3A1 upon LTP induction is absent
in GluN2A knock out mice. a Schematic presentation of LTP induction by high-frequency stimulation in acute CA1 hippocampal slices. Only
the potentiated CA1 region was dissected from individual hippocampal slices 6 h following LTP recordings. Representative traces from
recordings at the time points indicated under control and treatment conditions. b, c DNMT3A1 levels are reduced 6 h after LTP induction and
neddylation inhibition prevented the degradation of Dnmt3A1. β-Actin was used as an internal control for normalization. Two-way ANOVA
followed by Bonferroni’s post hoc test. **p < 0.01, *p < 0.05. d Averaged fEPSP slopes of the last hour following LTP induction showed
significantly reduced LTP in MLN4924 (50 nM) treated slices in comparison to slices treated by DMSO. Mann–Whitney U-Test ***p < 0.001.
e Application of MLN4924 for 6 h induces significantly impaired LTP as compared to controls. *p < 0.05 and **p < 0.01. f Baseline recordings
revealed no alterations. g, h GluN2A knockout (KO) mice show higher DNMT3A1 protein levels in the CA1 region of the hippocampus
compared to the age-matched wild type (WT) control mice. unpaired Student’s t-test **p < 0.01. i–l Quantitative immunoblotting either from
the CA1 of WT (i, j) or GluN2A KO (k, l) mice revealed no reduction in the GluN2A KO mice following 3 h of LTP recordings unlike reduction
seen in the WT control mice tissue. Unpaired Student’s t-test. *p < 0.05, n.s. not significant. Error bars present S.E.M. Sample numbers for each
experimental group indicate potentiated pooled CA1 slices from at least three different recordings or mice used per group.
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questions about the underlying mechanism of long-distance
signaling and the rationale behind it. Since GluN2A-containing
NMDARs are in contrast to those containing GluN2B preferentially
found at synaptic sites [49], it is possible if not likely that steep and
fast synaptic Ca2+-influx through these receptors is necessary to
elicit nuclear Ca2+-responses that in turn enhance neddylation of
Cullins in a CaMKIV-dependent manner. Neddylation as such has
not been investigated in any detail in neurons yet and not much
information is currently available on how NAE activity itself is
regulated. The present study, therefore, provides first evidence
that an NMDAR-derived synaptic calcium signal is coupled to
neddylation of Cullins in the nucleus. Two previous reports have
shown that blocking neddylation for extended periods of time (in
contrast to the administration regime in the present study) leads
to reductions in spine size and impairment of synapse maturation
in neurons [34, 35]. In addition, neddylation alters synapse
function and morphology by directly modifying one of the major
synaptic scaffolding proteins PSD95 [35]. We found that NEDD8 is
most abundant in neuronal nuclei and it is tempting to speculate
that activity-dependent neddylation might reduce the protein
levels not only of DNMT3A1 but also of other nuclear epigenetic
modifiers, which contribute to object location memory. Along
these lines the contribution of neddylation to object location
memory seems to be substantial, considering the near-complete
removal of the discrimination upon the inhibition of neddylation.
This is, however, not reflected in the extent of reduction in the
levels of DNMT3A1 induced by the behavioral training. Moreover,
neddylation, like other post-translational modifications, is rever-
sible, which adds potentially another level of regulation. In
addition, different efficiencies of proteasomal degradation in
neuronal sub-compartments, the necessity for the integration of
signaling pathways in the nucleus as well as complex formation
and potential nuclear export of ubiquitinated DNMT3A1 may
account for the relatively slow decline.
The proposed long-distance signaling pathway can provide a
potential link between different observations. Converging evi-
dence suggests that NMDAR function in the dorsal CA1 area is
critical for novel object location memory [45, 46] and increased
BDNF expression in the hippocampal CA1 region supports object
location learning [47, 48]. We have, therefore, chosen Bdnf as a
paradigmatic example for our studies, which is one of the target
genes that undergoes promoter-specific DNA demethylation in
the CA1 region of the hippocampus during memory consolidation
[14] and impaired spatial learning and memory, as well as
attenuated CA1-LTP, have been reported following a forebrain
specific Dnmt1 and -3 gene knockout in principal neurons [16, 17].
Aberrant DNA methylation has been implicated in a plethora of
studies on neuropsychiatric diseases including schizophrenia,
bipolar, and major depressive disorders [1, 7, 8]. One of the
hallmarks of schizophrenia is a downregulation of BDNF expres-
sion that is associated with the enrichment of 5-methylcytosine at
gene regulatory domains within the Bdnf promoter [50]. Moreover,
elevated hippocampal DNMT3A expression has been reported in
the postmortem brain of schizophrenia patients [51].
Collectively our data point to a mechanism that allows for the
synaptic control of DNMT3A1 levels and thereby creates a time
window for reduced de novo DNA methylation at a subset of
target genes. DNMT3A1-mediated methylation has been largely
associated with the silencing of promoters, which would in turn
attenuate activity-dependent gene expression. A shorter splice
isoform, DNMT3A2, was shown to associate with transcription of
plasticity-relevant genes presumably via methylation of CpG
islands in their promoter and coding regions [52, 53]. Dnmt3a2
is an immediate early gene that is identical to Dnmt3a1 except
that it lacks the sequence encoding the N-terminal 219 amino
acids of the enzyme, which encompasses the epitope of the
antibody that was used in the current study. Intriguingly, we
found increased expression of Dnmt3a2 mRNA (Fig. S3I) and
downregulation of DNMT3A1 is induced by the same stimulus, i.e.
activation of synaptic GluN2A-containing NMDARs. It is currently
unknown whether Dnmt3a2 mRNA will be immediately translated,
as expected for an immediate early gene. In this case, it may not
replace DNMT3A1 but independently facilitate activity-dependent
gene expression.
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Fig. 5 Inhibition of neddylation in CA1 impairs object location memory and the learning-induced degradation of DNMT3A1. a Schematic
representation of the experimental protocol for object location memory. b, c DNMT3A1 protein levels are reduced 3 h after training. Unpaired
Student’s t-test *p < 0.05. d, e DNMT3A1 protein levels are not changed in trained mice 6 h after training. Histone was used as a loading
control for normalization. Unpaired Student’s t-test n.s.= not significant. f Injection timeline and representative image of injection site in CA1.
g Intra-hippocampal infusion of MLN4924 reduces the discrimination index of animals tested in the object location memory test. Unpaired
Student’s t-test with Welch correction ***p < 0.001. h, i Learning induced reduction of DNMT3A1 protein levels in trained, but not MLN4924
injected mice 3 h after training. Unpaired two-tailed Student’s t-test *p < 0.01. j, k DNMT3A1 protein levels were not altered in trained
MLN4924 injected or control mice 6 h after training. Histone was used as a loading control for normalization. Data are represented as mean ±
S.E.M. Unpaired Student’s t-test *p < 0.05. Sample numbers for each experimental group indicate mice used per group.
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